Home    |    Contact Us    |    About Cerus    |    Site Map
A Single Pathogen Inactivation System for Both Platelets and Plasma The INTERCEPT Blood System™ is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. It is the first and only system available to treat plasma and platelets, and simplifies processing by utilizing the same illumination device, process and active compound. This synergistic approach is designed to meet blood center requirements for efficiency, performance and compatibility with both whole blood and apheresis collections. More

   NEWS & FEATURES

Cerus Enters into Agreement to Supply INTERCEPT Platelet System to Largest Region of German Red Cross (June 11) More

Cerus Receives Label Expansion on CE Marks for Use of INTERCEPT Blood System (April 21) More

The INTERCEPT Blood Systems for platelets and plasma are CE marked and produced to ISO 13485 Quality Standard.
UNITED STATES RESIDENTS
This site is intended for use by healthcare professionals outside of the United States only. If you are a resident of the United States, please see important information HERE.		   OVER 30 INTERCEPT ABSTRACTS AT ISBT
The 2008 ISBT scientific program featured extesive data for INTERCEPT Platelets, Plasma and Red Blood Cells. View the ISBT abstract list and other new publications here. More
© Cerus Corporation. All Rights Reserved.

Use of the INTERCEPT Blood System in the United States is limited by Federal law to investigational use. If you are a resident of the U.S., please click here.

The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located. The INTERCEPT Blood System is CE marked for use with platelets and plasma.

Website design by NetPilot Web Solutions
Legal Info  |   Privacy Policy